SCHOOL OF MEDICINE

Entries in "CaseMED Weekly"

Study finds receptor that may be linked to Alzheimer's

A receptor that acts as a kind of traffic cop in the brain appears to be linked to Alzheimer's disease, an international study has found. The Case Western Reserve University School of Medicine participated in the international collaboration, which provided an important clue in how plaque finds its way to the decaying brains of Alzheimer's patients.

http://www.cleveland.com/news/plaindealer/index.ssf?/base/news/116920803649660.xml&coll=2

Arteriocyte Inc. Completes Phase I Stem Cell Clinical Trial Enrollment; Will Present Update at TCT2006 Meeting

CLEVELAND--(BUSINESS WIRE)--Arteriocyte, Inc., a clinical stage research and development company focused on creating stem cell therapies for the treatment of vascular diseases, announced today that it has reached the three month patient follow-up point for its SEACOAST Phase I clinical trial. The study is evaluating the safety of ACY001, Arteriocyte's lead cellular therapy product. ACY001 is an adult stem cell therapy harvested from bone marrow to treat chronic ischemia, a serious form of heart disease.
For More Information

Testing

Testing